U.S. Intrauterine Devices Market size to surpass $3.4 billion by 2032

U.S. Intrauterine Devices Market size is anticipated to  exceed USD 3.4 billion by 2032, as per a new research report announced by Global Market Insights Inc.
 

 Growing cases of unwanted pregnancies in the U.S. has proliferated the demand for contraceptives such as IUDs. Unintended pregnancies impose a financial strain on the country’s healthcare system as public spending on it is considerable. Moreover, its prevalence is also higher in the U.S. than in other developed countries. Better access to effective contraception reduces the incidence of abortion and unwanted pregnancies. Efforts to support and promote the use of contraceptives, including IUDs, are positively shaping the industry outlook.
 

Long-lasting effects of copper IUDs to foster product segment landscape

U.S. intrauterine devices market size from copper IUD segment is poised to hit USD 456.5 million by 2032. Copper IUD can be used as an emergency contraceptive and offers the added benefit of long-term and highly effective contraception. Additionally, studies have shown that copper IUDs also require less maintenance and have a 99% efficacy in preventing pregnancies. It is a hormone-free option for long-lasting and reversible birth control. 

Browse key industry insights spread across 210 pages with 283 market data tables & 15 figures & charts from the report, “U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/us-intrauterine-devices-market
 

Rising awareness to drive IUD use in 25-29 age group segment

U.S. intrauterine devices industry valuation from the 25-29 segment is likely to grow over USD 788 million by 2032, driven by surging awareness among women in this age group about the benefits of IUD and the implications of unwanted pregnancy. The segment progress can also be attributed to technological innovations in the field that yield fewer complications and lead to effective contraception for preventing unintended pregnancies and abortions. Furthermore, the availability of levonorgestrel-releasing and smaller frameless copper devices for adolescents and nulliparous women is also fostering segment outlook.
 

Surging incidence of abortions to strengthen Pacific Central intrauterine devices market

U.S. intrauterine devices market share from the Pacific Central segment is set to grow at a CAGR 9.5% by 2032, on account of increasing prevalence of unwanted pregnancies and abortions in the region. Moreover, strong presence of advanced care units in the states of Pacific Central zone is also contributing to zonal growth. In fact, in Oregon, The Oregon ContraceptiveCare Program (CCare) is a program that utilizes Medicaid waiver funding for preventing pregnancies.
 

Expansion strategies to define the competitive landscape for U.S. intrauterine devices market

Some leading U.S. intrauterine devices industry players include Bayer AG, Allergan (AbbVie, Inc.), and CooperSurgical Inc. (CooperCompanies), among others. Many of these players are emphasizing development strategies to sustain their industry leadership.